Mumbai, Aug. 22 -- Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations

(FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.

Published by HT Digital Content Services with permission from Capital Market....